Summary: BTL’s Emsculpt Neo has received FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation, expanding its original use for fat reduction and muscle building to now address medical conditions and improve patients’ mobility and recovery.
Key Takeaways
- Emsculpt Neo has received FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation purposes.
- The device is now approved for preventing disuse atrophy, muscle re-education, increasing range of motion, and improving circulation.
- Its application extends to post-surgery recovery, mobility improvement, and injury prevention for various patients, including the elderly and athletes.
————————————————————————————————————————————————
BTL announces that Emsculpt Neo has nabbed U.S. FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation. Originally launched in 2020 for fat reduction and muscle building, Emsculpt Neo now expands in 2024 to address medical conditions, with the goal of enhancing patients’ quality of life.
Boosting Mobility and Enhances Circulation
Emsculpt Neo is now cleared for preventing disuse atrophy, muscle re-education, increasing range of motion, preventing post-surgical calf muscle thrombosis, relaxing muscle spasms, and enhancing local circulation.
“Emsculpt Neo not only improves appearance but also function,” says Mohamed M. Abdulhamid, MD, FAANS, a board-certified neurosurgeon specializing in minimally invasive spine surgery. “Its abilities have changed my patients’ lives, helping them regain strength and mobility after surgery where traditional therapy fell short. Watching them recover confidence and movement was transformative.”
Addressing Medical and Aesthetic Needs
The application of Emsculpt Neo now spans rehabilitation after surgery, individuals seeking improved mobility and flexibility, older adults addressing age-related decline, recreational athletes looking to prevent injuries, and professional athletes managing muscle strain. With over 4 million treatments performed, Emsculpt Neo continues to deliver outcomes for muscle building and fat reduction.
“This FDA clearance opens new possibilities for Emsculpt Neo, bringing more patients into care,” said Rohit Mishra, director of product management. “We are focused on evolving this platform to meet the demands of both medical and aesthetic needs.”